ArticleEye (London, England)2019
Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.
Article in Eye (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.
- A Systematic Review and Meta-Analysis of the Success Rate of the Primary Probing in Pediatric Patients with Congenital Nasolacrimal Duct Obstruction in Different Age Groups.Medicina (Kaunas, Lithuania) · 2025Pooled it
- Dacryoendoscopy in patients with lacrimal outflow obstruction: a systematic review.International ophthalmology · 2025Pooled it
- Clinical Implication of Dacryoendoscopy in the Patients with Tearing: A Systematic Review.Korean journal of ophthalmology : KJO · 2023Pooled it
- Developmental anatomy of the lacrimal sac fossa and nasolacrimal canal: a CT study of paediatric patients.Eye (London, England) · 2026Observational
- Endoluminal lacrimal duct recanalization for pediatric secondary acquired lacrimal duct obstruction following epidemic keratoconjunctivitis.Japanese journal of ophthalmology · 2026Observational
- Dacryoendoscopy as a frontier technology for lacrimal drainage disorders.Japanese journal of ophthalmology · 2025Review
- Diagnostic Accuracy of the Fluorescein Efflux Test for Congenital Nasolacrimal Duct Obstruction.Cureus · 2025Article
- Pediatric dacryolith masquerading as congenital nasolacrimal duct obstruction.American journal of ophthalmology case reports · 2024Article
- Congenital nasolacrimal duct obstruction: clinical guideline.Japanese journal of ophthalmology · 2024Article
- Diversity in Lacrimal Pathway Morphology Among Patients with Congenital Nasolacrimal Duct Obstruction.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Comparison of Outcomes of Silicone Tube Intubation with or without Dacryoendoscopy for the Treatment of Congenital Nasolacrimal Duct Obstruction.Journal of clinical medicine · 2023Article
- Assessment of Office-Based Probing with Dacryoendoscopy for Treatment of Congenital Nasolacrimal Duct Obstruction: A Retrospective Study.Journal of clinical medicine · 2023Article
- Nasal endoscopy-guided primary nasolacrimal duct intubation for congenital nasolacrimal duct obstruction in children older than 4 years.International ophthalmology · 2023Article
- Comparison of the efficacies of 1.0 and 1.5 mm silicone tubes for the treatment of nasolacrimal duct obstruction.Scientific reports · 2022Observational
- Long-term Efficacy of Dacryoendoscopy-guided Recanalization and Silicone Tube Intubation.Korean journal of ophthalmology : KJO · 2022Article
- Improvement in Dacryoendoscopic Visibility after Image Processing Using Comb-Removal and Image-Sharpening Algorithms.Journal of clinical medicine · 2022Article
- Can preoperative lacrimal endoscopic evaluation change the paradigm of conventional lacrimal surgery?Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022Article
- Analysis of Lacrimal Duct Morphology from Cone-Beam Computed Tomography Dacryocystography in a Japanese Population.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Lacrimal Duct Obstruction and Infection Associated with Non-Traumatic Corneal Perforation: A Case Series.International medical case reports journal · 2022Article
- Improvement in Contrast Sensitivity Function after Lacrimal Passage Intubation in Eyes with Epiphora.Journal of clinical medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo examine the causes of congenital nasolacrimal duct obstruction (CNLDO) using dacryoendoscopy, and to evaluate the surgical outcomes of primary transcanalicular endoscopic dacryoplasty.
methodsThe subjects of this study were a total of 56 eyes of 46 Japanese children aged one to five years old (mean, 29.1 ± 14.0 months old) with clinically diagnosed CNLDO. The blockage was visualized and probed using a dacryoendoscope (MD10 with a 20 G probe, Fiber Tech Co., Ltd., Japan) under general anesthesia. We used a self-retaining bicanalicular lacrimal stent (Lacrifast®, Kaneka Co., Ltd., Japan) for nasolacrimal duct intubation.
resultsIn each case the obstruction was found to be caused by a single focal blockage at the distal end of the duct. A nasolacrimal dacryolith was observed in 5 eyes (9%) and successfully removed using the dacryoendoscope. The success rate of probing by subsequent nasolacrimal duct intubation was 100%. No complications were observed.
conclusionsWe obtained a 100% success rate with primary transcanalicular endoscopic dacryoplasty for the treatment of CNLDO. Direct visualization inside the lacrimal passage allowed for precise probing, even in infants, leading to successful treatment of CNLDO without any complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.